Inmune Bio (INMB)
INmune Bio Inc., a clinical-stage immunology company, focuses on developing drugs to reprogram the patients innate immune system to treat disease in the United...
- Open
- 2.270
- High
- 2.450
- Low
- 2.220
- Prev. Close
- 2.270
- Volume
- 320.55K
- Turnover
- 755.04K
- Avg Price
- 2.355
- Bid/Ask Ratio
- 33.33%
- Amplitude
- 10.13%
- 52wk High
- 2.499
- Volume Ratio
- 0.96
- Turnover Ratio
- 1.38%
Inmune Bio Analyst Rating
View moreForecast & Rating
Aug 26, 2026Price forecast
$7.00186.89%
Forecast & RatingStrong buy
4analysts
- Strong buy75.00%
- Buy25.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
